Business Wire

CA-PIVOT-BIO

11.11.2022 13:01:36 CET | Business Wire | Press release

Share
Pivot Bio Joins AIM for Climate as Innovation Sprint Partner

Pivot Bio, agriculture’s leading nitrogen innovator, joins the Agriculture Innovation Mission for Climate (AIM for Climate) as an Innovation Sprint Partner, committing at least $291 million in product development funding over four years to accelerate the adoption of climate-resilient microbial nitrogen fertilizers.

Pivot Bio introduced the world’s first nitrogen-producing microbes to U.S. farmers in 2018. Since that time, the company has introduced multiple microbial nitrogen products for wheat, sorghum and other small grains in addition to its flagship product for corn. Farmers have quickly converted their nitrogen management programs to include nitrogen produced by Pivot Bio’s microbes, while reducing their dependence on synthetic nitrogen fertilizer.

“Microbial nitrogen fertilizer has the potential to permanently and immediately deliver reductions in GHG emissions, while delivering co-benefits to watershed health, biodiversity, and farmer margins,” said Karsten Temme, Ph.D., co-founder and CEO of Pivot Bio. “This could be one of the most important technologies for accelerating progress against the world’s 2030 Sustainable Development Goals.”

Adhering to the root of the plants, Pivot Bio’s microbes convert atmospheric nitrogen to a usable source of the critical nutrient throughout a crop’s growing season. These microbes stay with the plant, eliminating the waste associated with fossil fuel-dependent synthetic fertilizers that are applied on top of the ground. Unlike synthetic fertilizers, Pivot Bio’s microbial fertilizer does not leach into waterways nor volatilize into the air, improving air and water quality.

“Farmers are the foundation of the world’s food system and humanity's greatest stewards of our land,” said Temme. “Pivot Bio is committed to partnering with them to deliver better nitrogen while helping to heal the planet.”

Over the next four years, Pivot Bio will continuously improve the nitrogen production capacity of the Company’s microbes and expand into new geographic markets to help more of the world’s farmers nourish their crops with the most climate-friendly and easy-to-use nitrogen on the market.

“As an AIM for Climate Innovation Sprint Partner, we will bring together the best minds and ideas to accelerate our pace of product development and increase farmer access to a dependable and sustainable nitrogen,” said Temme. “We are working toward a world where microbial nitrogen is the main source of crop nutrition and encourage farmers, government leaders and members of the private sector to get in touch to join us in that mission.”

COP27, the United Nations Climate Change Conference, has been called the “food COP,” devoting an entire day, November 12, to agriculture for the first time. Conservative estimates place the total emissions associated with synthetic nitrogen fertilizer at approximately 9 units of CO2eq for every unit of synthetic nitrogen fertilizer produced. Approximately one-third of those emissions are caused by the Haber-Bosch manufacturing process, with direct and indirect emissions of nitrous oxide (N2O) accounting for the rest. Replacing synthetic nitrogen fertilizer with nitrogen-producing microbes avoids these emissions and has the potential to reduce water use (more than 15,000 liters per ton of synthetic N fertilizer) and improve human health outcomes by reducing ozone depletion and particulate generation.

To learn more about Pivot Bio’s innovation sprint, please watch this video message.

About Pivot Bio:
At Pivot Bio, we believe in meeting the needs of the present without compromising the needs of future generations. Our unparalleled understanding of the crop microbiome will help create a future with cleaner water and air. We are dedicated to providing farmers with solutions so they can grow high-quality, environmentally-responsible, and sustainably-focused crops that help feed families worldwide. For more information, visit www.pivotbio.com and follow us on LinkedIn, Twitter, and YouTube.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221111005122/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release

Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse

Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye